Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holcombe Grier

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexatePaul A Meyers, Cindy L Schwartz, Mark Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summaryRichard Gorlick, Peter Anderson, Irene Andrulis, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexatePaul A Meyers, Cindy L Schwartz, Mark Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summaryRichard Gorlick, Peter Anderson, Irene Andrulis, et al.
Pageof 2